

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of chronic inflammatory response (GO:0002676) | 9.31855662 |
| 2 | single fertilization (GO:0007338) | 8.64142545 |
| 3 | heterotypic cell-cell adhesion (GO:0034113) | 8.55617722 |
| 4 | indole-containing compound catabolic process (GO:0042436) | 8.52293662 |
| 5 | indolalkylamine catabolic process (GO:0046218) | 8.52293662 |
| 6 | tryptophan catabolic process (GO:0006569) | 8.52293662 |
| 7 | negative regulation of interleukin-10 production (GO:0032693) | 7.62119664 |
| 8 | positive regulation of type 2 immune response (GO:0002830) | 7.58633472 |
| 9 | tryptophan metabolic process (GO:0006568) | 7.34540408 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.87547805 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 5.77554582 |
| 12 | fertilization (GO:0009566) | 5.70708114 |
| 13 | amine catabolic process (GO:0009310) | 5.51400159 |
| 14 | cellular biogenic amine catabolic process (GO:0042402) | 5.51400159 |
| 15 | regulation of memory T cell differentiation (GO:0043380) | 5.47870759 |
| 16 | indolalkylamine metabolic process (GO:0006586) | 5.45197212 |
| 17 | negative regulation of interleukin-8 production (GO:0032717) | 5.41279781 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.37436562 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.30878558 |
| 20 | negative regulation of cell killing (GO:0031342) | 5.30878558 |
| 21 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 5.21680634 |
| 22 | negative regulation of T-helper cell differentiation (GO:0045623) | 5.21680634 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.89441079 |
| 24 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.88654394 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.83757749 |
| 26 | benzene-containing compound metabolic process (GO:0042537) | 4.80461070 |
| 27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.76284080 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 4.73086276 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.65878931 |
| 30 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.59674573 |
| 31 | digestion (GO:0007586) | 4.59103939 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51860717 |
| 33 | positive regulation of cell-cell adhesion (GO:0022409) | 4.51624220 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.51163697 |
| 35 | epithelial cell morphogenesis (GO:0003382) | 4.50634996 |
| 36 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.50631970 |
| 37 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 4.42927024 |
| 38 | negative regulation of T cell apoptotic process (GO:0070233) | 4.40708268 |
| 39 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.39861907 |
| 40 | negative regulation of endopeptidase activity (GO:0010951) | 4.38765596 |
| 41 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.34560880 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 4.30194140 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.24096099 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 4.21327258 |
| 45 | negative regulation of peptidase activity (GO:0010466) | 4.19347695 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.18558930 |
| 47 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 4.17839300 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 4.15232005 |
| 49 | defense response to protozoan (GO:0042832) | 4.14650625 |
| 50 | positive regulation of defense response to virus by host (GO:0002230) | 4.06355244 |
| 51 | negative thymic T cell selection (GO:0045060) | 4.03228122 |
| 52 | regulation of type 2 immune response (GO:0002828) | 3.98839301 |
| 53 | response to interleukin-15 (GO:0070672) | 3.97279655 |
| 54 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.96586969 |
| 55 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.93894009 |
| 56 | regulation of activation of Janus kinase activity (GO:0010533) | 3.89550884 |
| 57 | indole-containing compound metabolic process (GO:0042430) | 3.89538534 |
| 58 | regulation of T-helper cell differentiation (GO:0045622) | 3.88724864 |
| 59 | regulation of T-helper 1 type immune response (GO:0002825) | 3.88168946 |
| 60 | activated T cell proliferation (GO:0050798) | 3.88084637 |
| 61 | transepithelial transport (GO:0070633) | 3.87677776 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.86540334 |
| 63 | positive thymic T cell selection (GO:0045059) | 3.86278469 |
| 64 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.83470486 |
| 65 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.80996828 |
| 66 | positive regulation of antigen processing and presentation (GO:0002579) | 3.78019508 |
| 67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.77536751 |
| 68 | positive regulation of interleukin-17 production (GO:0032740) | 3.77226662 |
| 69 | response to protozoan (GO:0001562) | 3.76908366 |
| 70 | negative T cell selection (GO:0043383) | 3.76425899 |
| 71 | regulation of B cell differentiation (GO:0045577) | 3.74586917 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.69274878 |
| 73 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.66083451 |
| 74 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.63886685 |
| 75 | positive regulation of neutrophil migration (GO:1902624) | 3.63886685 |
| 76 | defense response to bacterium (GO:0042742) | 3.63037681 |
| 77 | sulfur amino acid catabolic process (GO:0000098) | 3.60338849 |
| 78 | reverse cholesterol transport (GO:0043691) | 3.58206493 |
| 79 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.57182588 |
| 80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.52897828 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.47604698 |
| 82 | N-acetylneuraminate metabolic process (GO:0006054) | 3.47558185 |
| 83 | thymic T cell selection (GO:0045061) | 3.44886273 |
| 84 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.42578559 |
| 85 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.42073462 |
| 86 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 3.38066234 |
| 87 | detection of bacterium (GO:0016045) | 3.35965910 |
| 88 | cellular response to exogenous dsRNA (GO:0071360) | 3.35032782 |
| 89 | negative regulation of protein autophosphorylation (GO:0031953) | 3.33909439 |
| 90 | cellular response to interleukin-15 (GO:0071350) | 3.23833009 |
| 91 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.19030110 |
| 92 | response to bacterium (GO:0009617) | 3.18217465 |
| 93 | type I interferon signaling pathway (GO:0060337) | 3.17334653 |
| 94 | cellular response to type I interferon (GO:0071357) | 3.17334653 |
| 95 | regulation of alpha-beta T cell differentiation (GO:0046637) | 3.15954198 |
| 96 | response to type I interferon (GO:0034340) | 3.15774171 |
| 97 | detection of other organism (GO:0098543) | 3.15738665 |
| 98 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14842358 |
| 99 | regulation of macrophage activation (GO:0043030) | 3.09571435 |
| 100 | positive regulation of T cell differentiation (GO:0045582) | 3.09379720 |
| 101 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.05114754 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.03849518 |
| 103 | positive regulation of lymphocyte differentiation (GO:0045621) | 3.01788469 |
| 104 | regulation of defense response to virus by host (GO:0050691) | 3.01225368 |
| 105 | positive regulation of natural killer cell activation (GO:0032816) | 3.00012895 |
| 106 | seminiferous tubule development (GO:0072520) | 24.9778230 |
| 107 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.99179686 |
| 108 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97488982 |
| 109 | positive regulation of immunoglobulin production (GO:0002639) | 2.95938555 |
| 110 | interferon-gamma secretion (GO:0072643) | 2.93985148 |
| 111 | B cell mediated immunity (GO:0019724) | 2.93830830 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92914406 |
| 113 | T cell selection (GO:0045058) | 2.92297035 |
| 114 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91194576 |
| 115 | regulation of interleukin-17 production (GO:0032660) | 2.91156195 |
| 116 | response to interferon-alpha (GO:0035455) | 2.91024162 |
| 117 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.90744851 |
| 118 | regulation of neutrophil migration (GO:1902622) | 2.90482227 |
| 119 | regulation of neutrophil chemotaxis (GO:0090022) | 2.90482227 |
| 120 | T cell proliferation (GO:0042098) | 2.89919185 |
| 121 | alpha-linolenic acid metabolic process (GO:0036109) | 2.89641196 |
| 122 | neutrophil activation involved in immune response (GO:0002283) | 2.89094485 |
| 123 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.88851915 |
| 124 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88449256 |
| 125 | regulation of lipoprotein metabolic process (GO:0050746) | 2.87335409 |
| 126 | positive T cell selection (GO:0043368) | 2.86999784 |
| 127 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.83811588 |
| 128 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.83603348 |
| 129 | negative regulation of proteolysis (GO:0045861) | 2.80608296 |
| 130 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79289300 |
| 131 | regulation of alpha-beta T cell activation (GO:0046634) | 2.78701357 |
| 132 | positive regulation of granulocyte differentiation (GO:0030854) | 2.78156936 |
| 133 | Peyers patch development (GO:0048541) | 2.78055069 |
| 134 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.78055069 |
| 135 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.77600247 |
| 136 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.77539412 |
| 137 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.77536277 |
| 138 | regulation of activated T cell proliferation (GO:0046006) | 2.76840882 |
| 139 | O-glycan processing (GO:0016266) | 2.74676368 |
| 140 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.71385191 |
| 141 | negative regulation of protein processing (GO:0010955) | 2.70329013 |
| 142 | negative regulation of protein maturation (GO:1903318) | 2.70329013 |
| 143 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70245098 |
| 144 | glial cell proliferation (GO:0014009) | 2.69304630 |
| 145 | cysteine metabolic process (GO:0006534) | 2.67863924 |
| 146 | positive regulation of interleukin-12 production (GO:0032735) | 2.67276304 |
| 147 | regulation of beta-amyloid formation (GO:1902003) | 2.64997755 |
| 148 | sialylation (GO:0097503) | 2.62181879 |
| 149 | ethanol oxidation (GO:0006069) | 2.61344844 |
| 150 | complement activation, alternative pathway (GO:0006957) | 2.60039792 |
| 151 | high-density lipoprotein particle remodeling (GO:0034375) | 2.59715217 |
| 152 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.57182647 |
| 153 | negative regulation of hydrolase activity (GO:0051346) | 2.52370275 |
| 154 | negative regulation of glycogen metabolic process (GO:0070874) | 2.51363508 |
| 155 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.49300952 |
| 156 | hormone catabolic process (GO:0042447) | 2.46477849 |
| 157 | negative regulation of interleukin-6 production (GO:0032715) | 2.45200594 |
| 158 | low-density lipoprotein particle clearance (GO:0034383) | 2.37947000 |
| 159 | regulation of endopeptidase activity (GO:0052548) | 2.37753926 |
| 160 | valine metabolic process (GO:0006573) | 2.34705858 |
| 161 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.32752076 |
| 162 | L-serine transport (GO:0015825) | 2.28286928 |
| 163 | regulation of interleukin-10 production (GO:0032653) | 2.26550614 |
| 164 | alpha-amino acid catabolic process (GO:1901606) | 2.26423591 |
| 165 | regulation of peptidase activity (GO:0052547) | 2.26147100 |
| 166 | lipid catabolic process (GO:0016042) | 2.24461063 |
| 167 | cellular amino acid catabolic process (GO:0009063) | 2.21260639 |
| 168 | regulation of T cell apoptotic process (GO:0070232) | 2.21037837 |
| 169 | negative regulation of T cell proliferation (GO:0042130) | 2.19177365 |
| 170 | myeloid cell homeostasis (GO:0002262) | 2.17859502 |
| 171 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.14997266 |
| 172 | myelin maintenance (GO:0043217) | 2.14932006 |
| 173 | response to misfolded protein (GO:0051788) | 2.14630853 |
| 174 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.14580228 |
| 175 | triglyceride catabolic process (GO:0019433) | 2.12035290 |
| 176 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.10806073 |
| 177 | protein-lipid complex remodeling (GO:0034368) | 2.07765975 |
| 178 | macromolecular complex remodeling (GO:0034367) | 2.07765975 |
| 179 | plasma lipoprotein particle remodeling (GO:0034369) | 2.07765975 |
| 180 | neutral lipid catabolic process (GO:0046461) | 2.05490841 |
| 181 | acylglycerol catabolic process (GO:0046464) | 2.05490841 |
| 182 | regulation of apoptotic cell clearance (GO:2000425) | 2.05033178 |
| 183 | COPI coating of Golgi vesicle (GO:0048205) | 2.04486708 |
| 184 | Golgi transport vesicle coating (GO:0048200) | 2.04486708 |
| 185 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.04006236 |
| 186 | L-phenylalanine catabolic process (GO:0006559) | 2.04006236 |
| 187 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.02243712 |
| 188 | positive regulation of sterol transport (GO:0032373) | 2.01573991 |
| 189 | positive regulation of cholesterol transport (GO:0032376) | 2.01573991 |
| 190 | regulation of T cell tolerance induction (GO:0002664) | 14.6993039 |
| 191 | production of molecular mediator involved in inflammatory response (GO:0002532) | 14.3885354 |
| 192 | positive regulation of tolerance induction (GO:0002645) | 12.5750890 |
| 193 | sperm capacitation (GO:0048240) | 11.2562669 |
| 194 | regulation of tolerance induction (GO:0002643) | 10.9396612 |
| 195 | kynurenine metabolic process (GO:0070189) | 10.4677046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.11789529 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 5.46876904 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.20476096 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 4.65013464 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.32706707 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 4.00199027 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.94034116 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.46386942 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.07674838 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.04881946 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.03941706 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.02469765 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.93466709 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.88154940 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87939354 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71670975 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.70159348 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.68741418 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.59858644 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.57455826 |
| 21 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.55222542 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.46120690 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.45012566 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43083793 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.38872950 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26656609 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24576800 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.22606342 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.21816671 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.18529600 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.16870687 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15893452 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.13288397 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11697793 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11254678 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10239355 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08939019 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 2.06610640 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04133290 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96386605 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.90384218 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.85786188 |
| 43 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.84306174 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.81870598 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81659589 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.81139850 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81061656 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80204979 |
| 49 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79383983 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.78739710 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71712524 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69099199 |
| 53 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.68284676 |
| 54 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.66616251 |
| 55 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.64081786 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62585570 |
| 57 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.62376946 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.61871101 |
| 59 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.60669187 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60095584 |
| 61 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.58846432 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58410169 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56368843 |
| 64 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.54471888 |
| 65 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.54396894 |
| 66 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.54396894 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54111979 |
| 68 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.52596760 |
| 69 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51845507 |
| 70 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.51618791 |
| 71 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48140553 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.47840648 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45401847 |
| 74 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.45089779 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44882255 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42627063 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42437983 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40269874 |
| 79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.39704994 |
| 80 | * GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.38065826 |
| 81 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37807055 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37262042 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.37230165 |
| 84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36705722 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.36173243 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.34994415 |
| 87 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.33589227 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32360421 |
| 89 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.29652565 |
| 90 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.28396845 |
| 91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27352825 |
| 92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27026052 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24927899 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24453335 |
| 95 | P68_20966046_ChIP-Seq_HELA_Human | 1.22847717 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22756188 |
| 97 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22321763 |
| 98 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22069293 |
| 99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.21720764 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21686067 |
| 101 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19278939 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18687361 |
| 103 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17963820 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16955057 |
| 105 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.16442349 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15759351 |
| 107 | * FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.15757958 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15750571 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15058548 |
| 110 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.14839600 |
| 111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14470780 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14153851 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13219472 |
| 114 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.12793188 |
| 115 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.12747767 |
| 116 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 1.10168634 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09504750 |
| 118 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.06895192 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05505569 |
| 120 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05048750 |
| 121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04890032 |
| 122 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04576313 |
| 123 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03860429 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03790931 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02199774 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02042657 |
| 127 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01759508 |
| 128 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01659378 |
| 129 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01533113 |
| 130 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00838020 |
| 131 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00647542 |
| 132 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00613801 |
| 133 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00537629 |
| 134 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.99992429 |
| 135 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99227589 |
| 136 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98605112 |
| 137 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98344676 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98069783 |
| 139 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97538908 |
| 140 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.97500743 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97470438 |
| 142 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.95862311 |
| 143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95633818 |
| 144 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95550140 |
| 145 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95030091 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92736509 |
| 147 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.92169109 |
| 148 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92023367 |
| 149 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91230143 |
| 150 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.90702700 |
| 151 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.90380121 |
| 152 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90191267 |
| 153 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.89466123 |
| 154 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89333209 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89237772 |
| 156 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89013807 |
| 157 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88778785 |
| 158 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87967411 |
| 159 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87543127 |
| 160 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87384648 |
| 161 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86422991 |
| 162 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86399729 |
| 163 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86222404 |
| 164 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85954164 |
| 165 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85834032 |
| 166 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.85692410 |
| 167 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85479294 |
| 168 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85189682 |
| 169 | * P300_27268052_Chip-Seq_Bcells_Human | 0.84631773 |
| 170 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84501262 |
| 171 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84375058 |
| 172 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84348268 |
| 173 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83969602 |
| 174 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83770251 |
| 175 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83300022 |
| 176 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83289494 |
| 177 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.83221256 |
| 178 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82782435 |
| 179 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81849243 |
| 180 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81634537 |
| 181 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81634537 |
| 182 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81572569 |
| 183 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.81459428 |
| 184 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81379598 |
| 185 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81283893 |
| 186 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81022877 |
| 187 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.79557493 |
| 188 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.78548770 |
| 189 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77589485 |
| 190 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76803124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 6.72205000 |
| 2 | MP0003303_peritoneal_inflammation | 5.14603677 |
| 3 | MP0002254_reproductive_system_inflammat | 5.03955434 |
| 4 | MP0001835_abnormal_antigen_presentation | 4.88490503 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 4.31677558 |
| 6 | MP0004043_abnormal_pH_regulation | 4.30990949 |
| 7 | MP0001790_abnormal_immune_system | 3.99983171 |
| 8 | MP0005387_immune_system_phenotype | 3.99983171 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.94704801 |
| 10 | MP0001800_abnormal_humoral_immune | 3.55973548 |
| 11 | MP0005671_abnormal_response_to | 3.37434666 |
| 12 | MP0002009_preneoplasia | 3.13368755 |
| 13 | MP0005000_abnormal_immune_tolerance | 3.07632145 |
| 14 | MP0000537_abnormal_urethra_morphology | 3.05388230 |
| 15 | MP0005410_abnormal_fertilization | 2.99999797 |
| 16 | MP0000685_abnormal_immune_system | 2.95437315 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.94655267 |
| 18 | MP0003436_decreased_susceptibility_to | 2.84520099 |
| 19 | MP0002723_abnormal_immune_serum | 2.73909215 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.69793061 |
| 21 | MP0009785_altered_susceptibility_to | 2.68646412 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.66047672 |
| 23 | MP0003329_amyloid_beta_deposits | 2.59224193 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.54856485 |
| 25 | MP0001819_abnormal_immune_cell | 2.51491281 |
| 26 | MP0003724_increased_susceptibility_to | 2.50290241 |
| 27 | MP0005025_abnormal_response_to | 2.49334217 |
| 28 | MP0002419_abnormal_innate_immunity | 2.49207389 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.48790484 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 2.46660758 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 2.42738698 |
| 32 | MP0001873_stomach_inflammation | 2.39079394 |
| 33 | MP0002168_other_aberrant_phenotype | 2.11723056 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 2.07712269 |
| 35 | MP0002398_abnormal_bone_marrow | 2.05168605 |
| 36 | MP0004381_abnormal_hair_follicle | 2.04515589 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.99447703 |
| 38 | MP0000716_abnormal_immune_system | 1.97352880 |
| 39 | MP0000003_abnormal_adipose_tissue | 1.88191644 |
| 40 | MP0000604_amyloidosis | 1.84476676 |
| 41 | MP0005360_urolithiasis | 1.84422828 |
| 42 | MP0010329_abnormal_lipoprotein_level | 1.83719923 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.81213123 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.76354812 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.74559070 |
| 46 | MP0002405_respiratory_system_inflammati | 1.73695284 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.73592869 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.71144480 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.68894140 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.67012403 |
| 51 | MP0005365_abnormal_bile_salt | 1.66594215 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.66421785 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.65418327 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.62555051 |
| 55 | MP0002722_abnormal_immune_system | 1.61726086 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.53091254 |
| 57 | MP0002429_abnormal_blood_cell | 1.52893912 |
| 58 | MP0004264_abnormal_extraembryonic_tissu | 1.48153211 |
| 59 | MP0001765_abnormal_ion_homeostasis | 1.45260433 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.40633482 |
| 61 | MP0009278_abnormal_bone_marrow | 1.39005863 |
| 62 | MP0003646_muscle_fatigue | 1.38987334 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.37775107 |
| 64 | MP0005085_abnormal_gallbladder_physiolo | 1.37253410 |
| 65 | MP0004885_abnormal_endolymph | 1.36673556 |
| 66 | MP0001853_heart_inflammation | 1.36524383 |
| 67 | MP0004185_abnormal_adipocyte_glucose | 1.35864203 |
| 68 | MP0000534_abnormal_ureter_morphology | 1.35747385 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.34354882 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.32841288 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.31137720 |
| 72 | MP0009643_abnormal_urine_homeostasis | 1.28988850 |
| 73 | MP0003828_pulmonary_edema | 1.28663353 |
| 74 | MP0004130_abnormal_muscle_cell | 1.28269143 |
| 75 | MP0003690_abnormal_glial_cell | 1.27795762 |
| 76 | MP0000538_abnormal_urinary_bladder | 1.26607984 |
| 77 | MP0001440_abnormal_grooming_behavior | 1.23286538 |
| 78 | MP0004858_abnormal_nervous_system | 1.22637633 |
| 79 | MP0001756_abnormal_urination | 1.22526700 |
| 80 | MP0004947_skin_inflammation | 1.19917381 |
| 81 | MP0008469_abnormal_protein_level | 1.18617262 |
| 82 | MP0005275_abnormal_skin_tensile | 1.17463845 |
| 83 | MP0004859_abnormal_synaptic_plasticity | 1.16574282 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 1.15220819 |
| 85 | MP0002396_abnormal_hematopoietic_system | 1.14499736 |
| 86 | MP0002006_tumorigenesis | 1.13540128 |
| 87 | MP0003866_abnormal_defecation | 1.11540929 |
| 88 | MP0002796_impaired_skin_barrier | 1.11177211 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10607438 |
| 90 | MP0004036_abnormal_muscle_relaxation | 1.10268096 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 1.10228341 |
| 92 | MP0000747_muscle_weakness | 1.09304313 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 1.07282507 |
| 94 | MP0005332_abnormal_amino_acid | 1.07093443 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 1.04746439 |
| 96 | MP0000372_irregular_coat_pigmentation | 1.04318706 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 1.02402986 |
| 98 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01811983 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.99350559 |
| 100 | MP0009764_decreased_sensitivity_to | 0.98621071 |
| 101 | MP0003632_abnormal_nervous_system | 0.96870958 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.94980325 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 0.94980325 |
| 104 | MP0010678_abnormal_skin_adnexa | 0.94958360 |
| 105 | MP0005083_abnormal_biliary_tract | 0.94763303 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.93803201 |
| 107 | MP0009379_abnormal_foot_pigmentation | 0.93220082 |
| 108 | MP0002132_abnormal_respiratory_system | 0.92431798 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.92041939 |
| 110 | MP0006082_CNS_inflammation | 0.91659601 |
| 111 | MP0000858_altered_metastatic_potential | 0.89998800 |
| 112 | MP0003075_altered_response_to | 0.88008706 |
| 113 | MP0003252_abnormal_bile_duct | 0.87721071 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.87373390 |
| 115 | MP0004484_altered_response_of | 0.86797977 |
| 116 | MP0001851_eye_inflammation | 0.86653070 |
| 117 | MP0003191_abnormal_cellular_cholesterol | 0.84419641 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.83778532 |
| 119 | MP0003698_abnormal_male_reproductive | 0.83556322 |
| 120 | MP0009763_increased_sensitivity_to | 0.82628724 |
| 121 | MP0003315_abnormal_perineum_morphology | 0.82466740 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.81269807 |
| 123 | MP0005310_abnormal_salivary_gland | 0.80055398 |
| 124 | MP0009780_abnormal_chondrocyte_physiolo | 0.78903696 |
| 125 | MP0002909_abnormal_adrenal_gland | 0.78840487 |
| 126 | MP0000920_abnormal_myelination | 0.78319538 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.77098595 |
| 128 | MP0005395_other_phenotype | 0.76140805 |
| 129 | MP0004510_myositis | 0.75418091 |
| 130 | MP0006138_congestive_heart_failure | 0.74994701 |
| 131 | MP0001663_abnormal_digestive_system | 0.73983445 |
| 132 | MP0003806_abnormal_nucleotide_metabolis | 0.73856296 |
| 133 | MP0002933_joint_inflammation | 0.73393258 |
| 134 | MP0000249_abnormal_blood_vessel | 0.73171053 |
| 135 | MP0003448_altered_tumor_morphology | 0.72943742 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.71438857 |
| 137 | MP0005385_cardiovascular_system_phenoty | 0.70988967 |
| 138 | MP0001544_abnormal_cardiovascular_syste | 0.70988967 |
| 139 | MP0002733_abnormal_thermal_nociception | 0.68140223 |
| 140 | MP0005670_abnormal_white_adipose | 0.67683402 |
| 141 | MP0003631_nervous_system_phenotype | 0.67384267 |
| 142 | MP0000609_abnormal_liver_physiology | 0.67225807 |
| 143 | MP0008874_decreased_physiological_sensi | 0.66520925 |
| 144 | MP0002127_abnormal_cardiovascular_syste | 0.65709281 |
| 145 | MP0003011_delayed_dark_adaptation | 0.65471185 |
| 146 | MP0000343_altered_response_to | 0.65310011 |
| 147 | MP0001666_abnormal_nutrient_absorption | 0.64626785 |
| 148 | MP0004270_analgesia | 0.64285736 |
| 149 | MP0005165_increased_susceptibility_to | 0.63768203 |
| 150 | MP0002138_abnormal_hepatobiliary_system | 0.63077440 |
| 151 | MP0009384_cardiac_valve_regurgitation | 0.62608989 |
| 152 | MP0003879_abnormal_hair_cell | 0.62346017 |
| 153 | MP0002295_abnormal_pulmonary_circulatio | 0.62034239 |
| 154 | MP0005319_abnormal_enzyme/_coenzyme | 0.61713210 |
| 155 | MP0002332_abnormal_exercise_endurance | 0.60456822 |
| 156 | MP0002095_abnormal_skin_pigmentation | 0.60451555 |
| 157 | MP0002876_abnormal_thyroid_physiology | 0.60140624 |
| 158 | MP0005408_hypopigmentation | 0.57906866 |
| 159 | MP0002019_abnormal_tumor_incidence | 0.57372750 |
| 160 | MP0003633_abnormal_nervous_system | 0.57221343 |
| 161 | MP0003635_abnormal_synaptic_transmissio | 0.55785089 |
| 162 | MP0009115_abnormal_fat_cell | 0.55433309 |
| 163 | MP0005623_abnormal_meninges_morphology | 0.55299938 |
| 164 | MP0009333_abnormal_splenocyte_physiolog | 0.55077906 |
| 165 | MP0005334_abnormal_fat_pad | 0.54804722 |
| 166 | MP0003123_paternal_imprinting | 0.54705265 |
| 167 | MP0005330_cardiomyopathy | 0.53938354 |
| 168 | MP0003634_abnormal_glial_cell | 0.53364624 |
| 169 | MP0001348_abnormal_lacrimal_gland | 0.53049733 |
| 170 | MP0005166_decreased_susceptibility_to | 0.50755570 |
| 171 | MP0002735_abnormal_chemical_nociception | 0.50474533 |
| 172 | MP0001881_abnormal_mammary_gland | 0.50018865 |
| 173 | MP0005164_abnormal_response_to | 0.49317424 |
| 174 | MP0005535_abnormal_body_temperature | 0.49015142 |
| 175 | MP0004019_abnormal_vitamin_homeostasis | 0.48595136 |
| 176 | MP0000462_abnormal_digestive_system | 0.48305638 |
| 177 | MP0009053_abnormal_anal_canal | 0.47174857 |
| 178 | MP0001970_abnormal_pain_threshold | 0.46819820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.71134951 |
| 2 | Testicular atrophy (HP:0000029) | 5.53327431 |
| 3 | Stomatitis (HP:0010280) | 5.50534307 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 5.24326054 |
| 5 | Myocardial infarction (HP:0001658) | 5.22993856 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.01038687 |
| 7 | Gonadotropin excess (HP:0000837) | 4.97376188 |
| 8 | Hypophosphatemic rickets (HP:0004912) | 4.74849385 |
| 9 | Colitis (HP:0002583) | 4.72090196 |
| 10 | Facial shape deformation (HP:0011334) | 4.67053634 |
| 11 | Potter facies (HP:0002009) | 4.67053634 |
| 12 | IgG deficiency (HP:0004315) | 4.61002963 |
| 13 | Vascular calcification (HP:0004934) | 4.52714327 |
| 14 | Complement deficiency (HP:0004431) | 4.31849795 |
| 15 | Cardiovascular calcification (HP:0011915) | 4.20068459 |
| 16 | Meningitis (HP:0001287) | 4.16750103 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 4.06385073 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.06385073 |
| 19 | Gastrointestinal stroma tumor (HP:0100723) | 4.04274344 |
| 20 | Neurofibrillary tangles (HP:0002185) | 4.02580430 |
| 21 | Myositis (HP:0100614) | 4.00635298 |
| 22 | Calf muscle hypertrophy (HP:0008981) | 3.94491796 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 3.93249294 |
| 24 | Genetic anticipation (HP:0003743) | 3.90111641 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 3.85892185 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.83394141 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.78930899 |
| 28 | Prostate neoplasm (HP:0100787) | 3.73370422 |
| 29 | Choroideremia (HP:0001139) | 3.73026139 |
| 30 | Recurrent bronchitis (HP:0002837) | 3.68952363 |
| 31 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.68034805 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.66240195 |
| 33 | Recurrent abscess formation (HP:0002722) | 3.65227591 |
| 34 | Malnutrition (HP:0004395) | 3.63121114 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 3.58812154 |
| 36 | Abnormality of the axillary hair (HP:0100134) | 3.41617174 |
| 37 | Abnormality of secondary sexual hair (HP:0009888) | 3.41617174 |
| 38 | Cellulitis (HP:0100658) | 3.40327781 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 3.38186785 |
| 40 | Recurrent sinusitis (HP:0011108) | 3.37832309 |
| 41 | Abnormality of T cells (HP:0002843) | 3.36133356 |
| 42 | Encephalitis (HP:0002383) | 3.35656152 |
| 43 | Recurrent viral infections (HP:0004429) | 3.29739501 |
| 44 | Abnormal hemoglobin (HP:0011902) | 3.26073539 |
| 45 | Vasculitis (HP:0002633) | 3.25621048 |
| 46 | Infantile muscular hypotonia (HP:0008947) | 3.24430446 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 3.19585079 |
| 48 | Recurrent skin infections (HP:0001581) | 3.18380529 |
| 49 | Abnormality of complement system (HP:0005339) | 3.16175703 |
| 50 | Orchitis (HP:0100796) | 3.14492642 |
| 51 | Verrucae (HP:0200043) | 3.13722216 |
| 52 | Papilloma (HP:0012740) | 3.13722216 |
| 53 | Abnormality of macrophages (HP:0004311) | 3.13067806 |
| 54 | Neoplasm of the heart (HP:0100544) | 3.10780880 |
| 55 | Optic neuritis (HP:0100653) | 3.09712879 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 3.09712879 |
| 57 | Choreoathetosis (HP:0001266) | 3.01510260 |
| 58 | Widely patent fontanelles and sutures (HP:0004492) | 2.99773698 |
| 59 | Agitation (HP:0000713) | 2.99548453 |
| 60 | Xanthomatosis (HP:0000991) | 2.94647274 |
| 61 | Deep venous thrombosis (HP:0002625) | 2.93144242 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.92853064 |
| 63 | Supranuclear gaze palsy (HP:0000605) | 2.92713814 |
| 64 | Rickets (HP:0002748) | 2.92458130 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.89972594 |
| 66 | Intention tremor (HP:0002080) | 2.89098260 |
| 67 | Ketoacidosis (HP:0001993) | 2.76925638 |
| 68 | Viral hepatitis (HP:0006562) | 2.76110213 |
| 69 | Lymphopenia (HP:0001888) | 2.73549244 |
| 70 | Facial diplegia (HP:0001349) | 2.71670092 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.69052676 |
| 72 | Clumsiness (HP:0002312) | 2.62175157 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.56605141 |
| 74 | Hemiplegia (HP:0002301) | 2.56470770 |
| 75 | Congenital stationary night blindness (HP:0007642) | 2.56330581 |
| 76 | Chest pain (HP:0100749) | 2.56115467 |
| 77 | T lymphocytopenia (HP:0005403) | 2.55996625 |
| 78 | Gingivitis (HP:0000230) | 2.55040014 |
| 79 | Pustule (HP:0200039) | 2.53594253 |
| 80 | Recurrent lower respiratory tract infections (HP:0002783) | 2.50544574 |
| 81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.47248871 |
| 82 | Increased IgM level (HP:0003496) | 2.44126097 |
| 83 | Villous atrophy (HP:0011473) | 2.42983231 |
| 84 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.42983231 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.41984843 |
| 86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41514977 |
| 87 | Thyroid-stimulating hormone excess (HP:0002925) | 2.41418637 |
| 88 | Restrictive lung disease (HP:0002091) | 2.39780232 |
| 89 | Abnormality of T cell number (HP:0011839) | 2.39486067 |
| 90 | Ketosis (HP:0001946) | 2.39189001 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 2.37302058 |
| 92 | Intrahepatic cholestasis (HP:0001406) | 2.37188454 |
| 93 | Osteomyelitis (HP:0002754) | 2.36830926 |
| 94 | Arterial thrombosis (HP:0004420) | 2.36598904 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.36250210 |
| 96 | Ragged-red muscle fibers (HP:0003200) | 2.34353755 |
| 97 | Gingival bleeding (HP:0000225) | 2.33667710 |
| 98 | Abnormality of the fovea (HP:0000493) | 2.33613238 |
| 99 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32698958 |
| 100 | Obstructive lung disease (HP:0006536) | 2.32698958 |
| 101 | Decreased subcutaneous fat (HP:0001002) | 2.29874059 |
| 102 | Spastic diplegia (HP:0001264) | 2.27240873 |
| 103 | Emphysema (HP:0002097) | 2.26108144 |
| 104 | Abnormality of the prostate (HP:0008775) | 2.25552797 |
| 105 | Polar cataract (HP:0010696) | 2.24725518 |
| 106 | Keratoconjunctivitis sicca (HP:0001097) | 2.24533660 |
| 107 | Epistaxis (HP:0000421) | 2.23955906 |
| 108 | Keratoconjunctivitis (HP:0001096) | 2.22982975 |
| 109 | Recurrent pneumonia (HP:0006532) | 2.21622942 |
| 110 | Increased connective tissue (HP:0009025) | 2.19802429 |
| 111 | IgM deficiency (HP:0002850) | 2.19301636 |
| 112 | Hyperglycinuria (HP:0003108) | 2.19111902 |
| 113 | Acanthosis nigricans (HP:0000956) | 2.18988214 |
| 114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18684246 |
| 115 | Hyporeflexia of lower limbs (HP:0002600) | 2.18561960 |
| 116 | Sepsis (HP:0100806) | 2.18370016 |
| 117 | Testicular neoplasm (HP:0010788) | 2.18369251 |
| 118 | Hemoptysis (HP:0002105) | 2.17363384 |
| 119 | Leukocytosis (HP:0001974) | 2.17276599 |
| 120 | Difficulty running (HP:0009046) | 2.16841239 |
| 121 | Azoospermia (HP:0000027) | 2.16373063 |
| 122 | Sudden death (HP:0001699) | 2.15201727 |
| 123 | Focal segmental glomerulosclerosis (HP:0000097) | 2.15173335 |
| 124 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.14124643 |
| 125 | Hypopigmentation of the fundus (HP:0007894) | 2.14005257 |
| 126 | Abnormality of the fingertips (HP:0001211) | 2.13827973 |
| 127 | Muscle fiber splitting (HP:0003555) | 2.13632959 |
| 128 | IgA deficiency (HP:0002720) | 2.13373829 |
| 129 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.12323653 |
| 130 | Progressive cerebellar ataxia (HP:0002073) | 2.11110060 |
| 131 | Gout (HP:0001997) | 2.10850949 |
| 132 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.08672316 |
| 133 | Papilledema (HP:0001085) | 2.08176428 |
| 134 | Thin bony cortex (HP:0002753) | 2.06784526 |
| 135 | Granulocytopenia (HP:0001913) | 2.04470743 |
| 136 | Abnormality of the columella (HP:0009929) | 2.03784843 |
| 137 | Skin nodule (HP:0200036) | 2.03743808 |
| 138 | Bifid scrotum (HP:0000048) | 2.03725008 |
| 139 | Abnormality of purine metabolism (HP:0004352) | 2.02192088 |
| 140 | Xerostomia (HP:0000217) | 2.02108595 |
| 141 | Pili torti (HP:0003777) | 2.01210113 |
| 142 | Peripheral hypomyelination (HP:0007182) | 2.00402234 |
| 143 | Chronic sinusitis (HP:0011109) | 2.00401839 |
| 144 | Thrombocytosis (HP:0001894) | 2.00163845 |
| 145 | Increased cerebral lipofuscin (HP:0011813) | 1.99400129 |
| 146 | Increased IgE level (HP:0003212) | 1.98671840 |
| 147 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98322880 |
| 148 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98322880 |
| 149 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.97717797 |
| 150 | Abnormality of glycine metabolism (HP:0010895) | 1.97717797 |
| 151 | Gait ataxia (HP:0002066) | 1.95348319 |
| 152 | Myokymia (HP:0002411) | 1.94598987 |
| 153 | Obstructive sleep apnea (HP:0002870) | 1.94113466 |
| 154 | Dysostosis multiplex (HP:0000943) | 1.93599075 |
| 155 | Abnormality of the calf musculature (HP:0001430) | 1.92620655 |
| 156 | Ulnar claw (HP:0001178) | 1.92253132 |
| 157 | Epidermoid cyst (HP:0200040) | 1.90764607 |
| 158 | Right ventricular cardiomyopathy (HP:0011663) | 1.89729304 |
| 159 | Ventricular fibrillation (HP:0001663) | 1.88196831 |
| 160 | Hyperlipoproteinemia (HP:0010980) | 1.87596546 |
| 161 | Fatigue (HP:0012378) | 1.87188870 |
| 162 | Systemic lupus erythematosus (HP:0002725) | 1.87145308 |
| 163 | Vertigo (HP:0002321) | 1.86541884 |
| 164 | Slow saccadic eye movements (HP:0000514) | 1.85641081 |
| 165 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.85473450 |
| 166 | Pulmonary fibrosis (HP:0002206) | 1.85411654 |
| 167 | Episodic fever (HP:0001954) | 1.84522911 |
| 168 | Leukopenia (HP:0001882) | 1.84520041 |
| 169 | Infertility (HP:0000789) | 1.83308948 |
| 170 | Hypertriglyceridemia (HP:0002155) | 1.83157962 |
| 171 | Glomerulosclerosis (HP:0000096) | 1.83063663 |
| 172 | Gastrointestinal dysmotility (HP:0002579) | 1.83031723 |
| 173 | Abnormality of eosinophils (HP:0001879) | 1.82951106 |
| 174 | Hematochezia (HP:0002573) | 1.82829295 |
| 175 | Osteomalacia (HP:0002749) | 1.82259983 |
| 176 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81183400 |
| 177 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80606875 |
| 178 | Mucopolysacchariduria (HP:0008155) | 1.80606875 |
| 179 | Ectopia lentis (HP:0001083) | 1.78892004 |
| 180 | Prominent nose (HP:0000448) | 1.78611781 |
| 181 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.77841814 |
| 182 | Restlessness (HP:0000711) | 1.76224018 |
| 183 | Hyperparathyroidism (HP:0000843) | 1.74821512 |
| 184 | Rectal prolapse (HP:0002035) | 1.74208273 |
| 185 | Wide cranial sutures (HP:0010537) | 1.74126596 |
| 186 | Hepatoblastoma (HP:0002884) | 1.71893825 |
| 187 | Hyperammonemia (HP:0001987) | 1.71295699 |
| 188 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.71158578 |
| 189 | Hyperpituitarism (HP:0010514) | 1.69439929 |
| 190 | Hypoalphalipoproteinemia (HP:0003233) | 1.68443099 |
| 191 | Tubulointerstitial fibrosis (HP:0005576) | 1.67399750 |
| 192 | Increased CSF protein (HP:0002922) | 1.64471698 |
| 193 | Progressive neurologic deterioration (HP:0002344) | 1.63385663 |
| 194 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.61713933 |
| 195 | Abnormal cartilage morphology (HP:0002763) | 1.59859285 |
| 196 | Hyperphosphatemia (HP:0002905) | 1.58456770 |
| 197 | Abnormality of the common coagulation pathway (HP:0010990) | 1.58324997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNK2 | 4.77442552 |
| 2 | MAP4K1 | 3.92999942 |
| 3 | FER | 3.78822459 |
| 4 | MST4 | 3.74168650 |
| 5 | MAP4K2 | 3.66867113 |
| 6 | PKN2 | 3.18390563 |
| 7 | TESK2 | 3.13531283 |
| 8 | LMTK2 | 2.99216479 |
| 9 | ERN1 | 2.86122561 |
| 10 | LRRK2 | 2.59346153 |
| 11 | SIK1 | 2.46880837 |
| 12 | EPHB1 | 2.45704710 |
| 13 | TXK | 2.41108740 |
| 14 | TRIB3 | 2.25012102 |
| 15 | JAK3 | 2.22058940 |
| 16 | PDGFRA | 2.16284882 |
| 17 | FGFR2 | 2.12249208 |
| 18 | BLK | 2.01978949 |
| 19 | MAP3K13 | 1.96241047 |
| 20 | GRK6 | 1.95458956 |
| 21 | FGFR4 | 1.91808671 |
| 22 | SYK | 1.84678524 |
| 23 | STK39 | 1.83130003 |
| 24 | KIT | 1.77270759 |
| 25 | BTK | 1.62011822 |
| 26 | WNK4 | 1.61652887 |
| 27 | TBK1 | 1.60972624 |
| 28 | PTK6 | 1.59970789 |
| 29 | TAOK3 | 1.59925177 |
| 30 | CDC42BPA | 1.48950531 |
| 31 | GRK1 | 1.48303900 |
| 32 | MAP3K14 | 1.45811822 |
| 33 | MAP3K2 | 1.45045727 |
| 34 | IRAK4 | 1.43730957 |
| 35 | NTRK1 | 1.41621231 |
| 36 | EPHA2 | 1.38017547 |
| 37 | FRK | 1.35246249 |
| 38 | TYRO3 | 1.32738663 |
| 39 | FLT3 | 1.32559413 |
| 40 | IKBKE | 1.32219580 |
| 41 | PRKD3 | 1.29284216 |
| 42 | IRAK3 | 1.28680637 |
| 43 | RET | 1.27893541 |
| 44 | HCK | 1.26103446 |
| 45 | TTN | 1.21001513 |
| 46 | PTK2 | 1.20447914 |
| 47 | CSF1R | 1.15430658 |
| 48 | CDK19 | 1.14979842 |
| 49 | NTRK3 | 1.14682671 |
| 50 | STK10 | 1.11770935 |
| 51 | ZAP70 | 1.11126291 |
| 52 | LYN | 1.09943086 |
| 53 | INSR | 1.07788313 |
| 54 | MARK2 | 1.06187869 |
| 55 | TEC | 1.05561260 |
| 56 | LCK | 1.04576465 |
| 57 | PTK2B | 1.02897128 |
| 58 | PAK3 | 0.99243985 |
| 59 | EEF2K | 0.98962964 |
| 60 | FGFR3 | 0.98959844 |
| 61 | SCYL2 | 0.97048985 |
| 62 | MAP2K3 | 0.93403966 |
| 63 | RIPK4 | 0.93123085 |
| 64 | MYLK | 0.92924650 |
| 65 | ADRBK2 | 0.92181207 |
| 66 | BCKDK | 0.90107613 |
| 67 | KDR | 0.89121441 |
| 68 | MAP2K4 | 0.88423751 |
| 69 | MAP3K1 | 0.87723606 |
| 70 | TESK1 | 0.84768641 |
| 71 | CDK5 | 0.84239737 |
| 72 | MAP3K12 | 0.82390571 |
| 73 | MET | 0.82013457 |
| 74 | MAP3K3 | 0.81649011 |
| 75 | PRKCH | 0.81125599 |
| 76 | PAK2 | 0.80824317 |
| 77 | IKBKB | 0.80150192 |
| 78 | PRPF4B | 0.79647954 |
| 79 | LATS2 | 0.77145468 |
| 80 | PDK3 | 0.75400803 |
| 81 | PDK4 | 0.75400803 |
| 82 | EPHB2 | 0.75043165 |
| 83 | MARK3 | 0.73966473 |
| 84 | KSR2 | 0.72367469 |
| 85 | DMPK | 0.71998963 |
| 86 | CDK12 | 0.71051021 |
| 87 | PAK6 | 0.70359473 |
| 88 | MATK | 0.69719175 |
| 89 | MAPK12 | 0.69590147 |
| 90 | MAP3K10 | 0.66332701 |
| 91 | PAK4 | 0.66080522 |
| 92 | MAPK7 | 0.65542918 |
| 93 | MAP3K7 | 0.65350844 |
| 94 | MST1R | 0.64696031 |
| 95 | SIK2 | 0.64517454 |
| 96 | JAK2 | 0.63267389 |
| 97 | WNK1 | 0.62540977 |
| 98 | MAP2K2 | 0.62163537 |
| 99 | PIK3CG | 0.62062885 |
| 100 | ROCK2 | 0.61788194 |
| 101 | YES1 | 0.60934459 |
| 102 | ALK | 0.60404571 |
| 103 | PRKD2 | 0.60346007 |
| 104 | TAOK1 | 0.60232079 |
| 105 | INSRR | 0.59999134 |
| 106 | GSK3A | 0.59531573 |
| 107 | STK11 | 0.58482254 |
| 108 | PHKG1 | 0.58403388 |
| 109 | PHKG2 | 0.58403388 |
| 110 | CDK6 | 0.58058464 |
| 111 | MAPK11 | 0.57518531 |
| 112 | SRC | 0.57194561 |
| 113 | CHUK | 0.56490736 |
| 114 | FGFR1 | 0.56411238 |
| 115 | PIM1 | 0.54381338 |
| 116 | MAP3K11 | 0.54039612 |
| 117 | MAP2K1 | 0.53879227 |
| 118 | PDGFRB | 0.52377235 |
| 119 | ITK | 0.51973278 |
| 120 | ILK | 0.51636590 |
| 121 | BMPR2 | 0.51011059 |
| 122 | CSNK1E | 0.50422262 |
| 123 | LATS1 | 0.50289159 |
| 124 | ICK | 0.49780866 |
| 125 | PRKCG | 0.48942475 |
| 126 | PRKCZ | 0.48404940 |
| 127 | FYN | 0.47888285 |
| 128 | NLK | 0.47278185 |
| 129 | SIK3 | 0.47262623 |
| 130 | NTRK2 | 0.47241859 |
| 131 | PDK1 | 0.45551519 |
| 132 | MAP3K6 | 0.45504719 |
| 133 | PINK1 | 0.45060130 |
| 134 | PDK2 | 0.45050778 |
| 135 | PRKCQ | 0.44919880 |
| 136 | CDK4 | 0.44441072 |
| 137 | PASK | 0.44329062 |
| 138 | MAPKAPK2 | 0.44075475 |
| 139 | JAK1 | 0.43930898 |
| 140 | UHMK1 | 0.43761708 |
| 141 | DDR2 | 0.43275627 |
| 142 | PRKD1 | 0.43263190 |
| 143 | AKT3 | 0.41950055 |
| 144 | EPHA4 | 0.41594573 |
| 145 | PRKACG | 0.40494550 |
| 146 | MINK1 | 0.39292797 |
| 147 | EGFR | 0.38686805 |
| 148 | MAPK4 | 0.38380780 |
| 149 | CSK | 0.37956770 |
| 150 | CAMK1G | 0.37651532 |
| 151 | MAP3K5 | 0.37568580 |
| 152 | FES | 0.37433264 |
| 153 | TYK2 | 0.37056489 |
| 154 | ADRBK1 | 0.36666223 |
| 155 | PDPK1 | 0.36452140 |
| 156 | TRPM7 | 0.36355185 |
| 157 | IGF1R | 0.35761559 |
| 158 | ERBB2 | 0.35720168 |
| 159 | OBSCN | 0.35646835 |
| 160 | MAPK3 | 0.35010724 |
| 161 | DAPK2 | 0.32672159 |
| 162 | ABL1 | 0.31639019 |
| 163 | HIPK2 | 0.30969928 |
| 164 | ARAF | 0.30951657 |
| 165 | PRKCD | 0.30539159 |
| 166 | CAMK4 | 0.29564953 |
| 167 | RPS6KL1 | 0.27620838 |
| 168 | RPS6KC1 | 0.27620838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.14011267 |
| 2 | Glutathione metabolism_Homo sapiens_hsa00480 | 4.36175260 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.22938760 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.76729817 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.72956744 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.64806563 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.57962577 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.53604710 |
| 9 | Asthma_Homo sapiens_hsa05310 | 3.50774396 |
| 10 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 3.45561405 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.39068372 |
| 12 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.32973903 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.06418208 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.96799271 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.72200479 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.68871211 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.53330819 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44410169 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 2.24606742 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.21091263 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19267219 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14523266 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96043396 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95659989 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.84834804 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83216955 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80564326 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.73034100 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.65185795 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63871852 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59584232 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57189422 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53742395 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52441635 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52032297 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48610893 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.45282505 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.37813660 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37195290 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33888431 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33749975 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.29340842 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.27314424 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25970747 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.23847593 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18260003 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16377299 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15903894 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.13197674 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08440263 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07291292 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06574653 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.06069501 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05748903 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04732941 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02448007 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01449511 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01384308 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00775935 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98617865 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.96771442 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96617592 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96478793 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.96445037 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96040270 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95441139 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.95304586 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.93990530 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93580386 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91708747 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90841914 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90310584 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.90100488 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87487364 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87170997 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86408443 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83336455 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82703926 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82208864 |
| 80 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80987319 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80472785 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80233634 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.79918303 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79288468 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78518155 |
| 86 | GABAergic synapse_Homo sapiens_hsa04727 | 0.78482882 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75090245 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71262774 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69686992 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68399686 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.67834694 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63847942 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63334174 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62460418 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61927232 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61347891 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60804771 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60457142 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59930868 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59904410 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58418942 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57470429 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56872069 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56098995 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.55416934 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.54898436 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54778501 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54056505 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52193232 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49708779 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48346664 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47550009 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47413622 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47164686 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46953711 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46377230 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45026406 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44600787 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.44029573 |
| 120 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43371546 |
| 121 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42818097 |
| 122 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.42236097 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.41768015 |
| 124 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41425897 |
| 125 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41344567 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40774794 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40763561 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40703243 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40041726 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39937954 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38072832 |
| 132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37765325 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37617015 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37408832 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36677242 |
| 136 | Peroxisome_Homo sapiens_hsa04146 | 0.36133055 |
| 137 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35740123 |
| 138 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.35088404 |
| 139 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35006673 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.33987464 |
| 141 | Apoptosis_Homo sapiens_hsa04210 | 0.33649805 |
| 142 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33302601 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33224226 |
| 144 | Insulin secretion_Homo sapiens_hsa04911 | 0.33215279 |
| 145 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.33176387 |
| 146 | Melanogenesis_Homo sapiens_hsa04916 | 0.32756714 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32462877 |
| 148 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31972028 |
| 149 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31737676 |
| 150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31275439 |
| 151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31207628 |
| 152 | Endocytosis_Homo sapiens_hsa04144 | 0.31154745 |
| 153 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31129695 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29805690 |
| 155 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29312742 |
| 156 | Insulin resistance_Homo sapiens_hsa04931 | 0.29269536 |
| 157 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29223265 |
| 158 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.28986232 |
| 159 | ABC transporters_Homo sapiens_hsa02010 | 0.28628881 |
| 160 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28581256 |
| 161 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.27160768 |
| 162 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26302797 |
| 163 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26090382 |
| 164 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25313566 |
| 165 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.25068336 |
| 166 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25050200 |
| 167 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24790418 |
| 168 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.24141552 |
| 169 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.23822864 |
| 170 | Legionellosis_Homo sapiens_hsa05134 | 0.23418804 |
| 171 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23413282 |
| 172 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.22186056 |
| 173 | Cocaine addiction_Homo sapiens_hsa05030 | 0.21617825 |

